Squarepoint
PGEN icon

Squarepoint’s Precigen PGEN Stock Holding History

Squarepoint’s Portfolio PGEN Stock Details PGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.01M Buy
353,272
+290,505
+463% +$1.26M ﹤0.01% 2342
2026
Q1 		$243K Sell
62,767
-16,311
-21% -$66.9K ﹤0.01% 3849
2025
Q4 		$331K Buy
79,078
+56,138
+245% +$217K ﹤0.01% 3525
2025
Q3 		$75.5K Buy
+22,940
New +$64.8K ﹤0.01% 4166
2024
Q4 		– Sell
-16,246
Closed -$15.4K – 5390
2024
Q3 		$15.4K Buy
+16,246
New +$20.5K ﹤0.01% 4036
2023
Q2 		– Sell
-177,282
Closed -$188K – 3897
2023
Q1 		$188K Buy
177,282
+159,351
+889% +$230K ﹤0.01% 2828
2022
Q4 		$27.3K Sell
17,931
-26,269
-59% -$45.2K ﹤0.01% 3097
2022
Q3 		$94K Sell
44,200
-34,047
-44% -$71.8K ﹤0.01% 2805
2022
Q2 		$105K Sell
78,247
-12,171
-13% -$18.1K ﹤0.01% 2610
2022
Q1 		$191K Sell
90,418
-8,885
-9% -$21.6K ﹤0.01% 2490
2021
Q4 		$368K Buy
99,303
+47,735
+93% +$205K ﹤0.01% 2341
2021
Q3 		$257K Sell
51,568
-109,104
-68% -$628K ﹤0.01% 2336
2021
Q2 		$1.05M Buy
160,672
+108,740
+209% +$760K ﹤0.01% 1595
2021
Q1 		$358K Buy
+51,932
New +$439K ﹤0.01% 2275
2020
Q4 		– Sell
-35,683
Closed -$125K – 3182
2020
Q3 		$125K Sell
35,683
-52,541
-60% -$249K ﹤0.01% 2236
2020
Q2 		$440K Buy
+88,224
New +$300K 0.01% 1378
2018
Q2 		– Sell
-10,880
Closed -$167K – 1974
2018
Q1 		$167K Sell
10,880
-110,691
-91% -$1.58M ﹤0.01% 1525
2017
Q4 		$1.4M Buy
121,571
+75,263
+163% +$1.12M 0.02% 680
2017
Q3 		$880K Sell
46,308
-1,381
-3% -$28.4K 0.02% 777
2017
Q2 		$1.15M Buy
+47,689
New +$1.05M 0.02% 676
2017
Q1 		– Sell
-41,702
Closed -$1M – 1824
2016
Q4 		$1M Buy
+41,702
New +$1.16M 0.04% 512
2016
Q1 		– Sell
-15,034
Closed -$449K – 1386
2015
Q4 		$449K Buy
+15,034
New +$507K 0.05% 594

Other funds holding PGEN

PCM
Patient Capital Management Baltimore, Maryland $3.05B AUM 42.09% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IAM
Iridian Asset Management Westport, Connecticut $291M AUM 49.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Squarepoint's PGEN Position: Q2 2026 in Review

Squarepoint increased its Precigen (PGEN) stake by 463% in Q2 2026, buying an estimated $1.26M and bringing the position to 353,272 shares worth $2.01M. The position accounts for ﹤0.01% of the portfolio, ranked #2342.

Squarepoint first reported a position in PGEN in Q4 2015 and has held it in 22 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Squarepoint held 353,272 shares of Precigen worth $2.01M as of Q2 2026.
  • Squarepoint bought 290,505 Precigen shares in Q2 2026, an estimated $1.26M.
  • Precigen made up ﹤0.01% of Squarepoint's portfolio in Q2 2026, its #2342 holding.
  • Squarepoint first reported a position in Precigen in Q4 2015 and has held it in 22 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.